<産業資料/調査レポートの題名> 2022年7月15日

動物向け感染症診断の世界市場:技術別(免疫診断(ラテラルフローアッセイ、ELISA)、分子診断)、動物別(コンパニオン、農場)、病原体別(細菌、ウイルス、寄生虫)、エンドユーザー別(ラボ、病院、クリニック、PoC)、地域別予測


◆英文タイトル:Global Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics (Lateral Flow Assays, ELISA), Molecular Diagnostics), Animal (Companion, Farm), Pathogen (Bacteria, Viral, Parasite), End-User (Lab, Hospital, Clinics, PoC) and Regional Forecasts 2019-2026

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Veterinary Infectious Disease Diagnostics Market, by Technology, 2016-2026 (USD Billion)
1.3.2. Veterinary Infectious Disease Diagnostics Market, by Animal, 2016-2026 (USD Billion)
1.3.3. Veterinary Infectious Disease Diagnostics Market, by End-User, 2016-2026 (USD Billion)
1.3.4. Veterinary Infectious Disease Diagnostics Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Veterinary Infectious Disease Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Veterinary Infectious Disease Diagnostics Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Veterinary Infectious Disease Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Veterinary Infectious Disease Diagnostics Market, by Technology
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Veterinary Infectious Disease Diagnostics Market, Sub Segment Analysis
5.3.1. Immunodiagnostics (Lateral Flow Assays, ELISA)
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2. Molecular Diagnostics
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Global Veterinary Infectious Disease Diagnostics Market, by Animal
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Veterinary Infectious Disease Diagnostics Market, Sub Segment Analysis
6.3.1. Companion
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Farm
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Global Veterinary Infectious Disease Diagnostics Market, by End-User
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Veterinary Infectious Disease Diagnostics Market, Sub Segment Analysis
7.3.1. Lab
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Hospital
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3. Clinics
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.4. PoC
7.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Global Veterinary Infectious Disease Diagnostics Market, by Regional Analysis
8.1. Veterinary Infectious Disease Diagnostics Market, Regional Market Snapshot (2016-2026)
8.2. North America Veterinary Infectious Disease Diagnostics Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3. Europe Veterinary Infectious Disease Diagnostics Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2. Rest of Europe
8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4. Asia Veterinary Infectious Disease Diagnostics Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5. Latin America Veterinary Infectious Disease Diagnostics Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6. Rest of The World
8.6.1. Middle East and Africa
8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.2. Technology breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.3. Animal breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.4. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. IDEXX Laboratories, Inc.
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Zoetis, Inc.
9.3.3. QIAGEN N.V.
9.3.4. Thermo Fisher Scientific, Inc.
9.3.5. Neogen Corporation
9.3.6. Virbac
9.3.7. BioMérieux SA
9.3.8. IDVet
9.3.9. Randox Laboratories, Ltd.
9.3.10. Heska Corporation
9.3.11. Creative Diagnostics
9.3.12. URIT Medical Electronic Group Co., Ltd
9.3.13. NTBIO Diagnostics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark